Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

InDex Pharmaceuticals Holding AB (publ) interim report January – March 2019

The final phase of the patient recruitment in the CONDUCT studyPeriod January – March 2019   ·  Revenues amounted to SEK 0.0 (0.1) million ·  Operating result amounted to SEK –17.2 (–18.8) million ·  Result after tax amounted to SEK –17.2 (–18.7) million, corresponding to SEK –0.25 per share (–0.30) before and after dilution ·  Cash flow from operating activities amounted to SEK –18.6 (–22.9) million ·  Cash and cash equivalents at the end of the period amounted to SEK 64.4 (102.1) million ·  Number of employees at the end of the period was 7 (7) ·  Number of shares

Interim Report, January–March 2019

Profitable quarter and successful share issue MSEK 750JANUARY–MARCH 2019 QUARTER · Revenue amounted to TSEK 53,361 (46,311). · Operating profit totalled TSEK 4,660 (-11,623). · Operating profit excluding items affecting comparability amounted to TSEK 4,660 (414). · Profit after tax amounted to TSEK 21,333 (-14,940). · Earnings per share amounted to SEK 0.71 (neg: 2.99). SIGNIFICANT EVENTS DURING THE QUARTER · The company has completed a rights issue providing the company with approx. MSEK 750 before deduction for issue costs. SIGNIFICANT EVENTS AFTER THE QUARTER

Gaming Innovation Group reports Q1 2019

Gaming Innovation Group Inc. (GiG) reports revenues of €32.4 million and an EBITDA of €4.1 million. “The Company delivered an EBITDA of €4.1m in Q1 and the key highlight was all time high revenues and EBITDA in our media business. It is a performance I am reasonably satisfied with in light of the loss of a major B2B customer which we announced in Q4-18, and the new regulation in Sweden which is impacting both our B2C and B2B revenues. We had anticipated this and managed the impact by careful cost control. The business is robust with cash flow from operating activities of €2.6m.GiG has

INPS – Equitalia Contact Center Service Tender

INPS General Direction Office has after two years deliberation awarded the assignment of the INPS Contact Center – Equitalia Service to a new group of service providers. After having reviewed the submitted proposals together with lawyers and pricing experts, the Covisian joint venture, of which Transcom is part, has decided to file an appeal. The group finds the price of the winning bid unrealistic on the basis of the technical offer and related price. The appeal was submitted on Friday, May 3. Transcom firmly believes that the bid submitted by the joint venture of which it is part is

Transcom signs asset transfer agreement with DPV to acquire ASA Informationsdienste GmbH

On April 18, 2019, Transcom Holding AB (publ) and its subsidiaries (”Transcom”) and DPV Deutscher Pressevertrieb GmbH signed an agreement to transfer assets and contracts from ASA Informationsdienste GmbH to Transcom Rostock. The transaction is expected to be effective from May 2019. ASA is one of the leading customer service provider specialized in the publishing and media industry in Germany. The company was founded in 1993 and has now been servicing the media industry for more than 25 years. ASA’s clients benefit from over 100 experienced and fully dedicated media experts that handle

Herantis Pharma publishes newsletter for March-April

Herantis Pharma publishes newsletter for March-April Herantis Pharma PlcPress release 6 May 2019 at 9:00 am Herantis Pharma plc (“Herantis”) has published its newsletter for March-April. The newsletter is also attached to this press release. Herantis’ newsletter is published every other month on the company’s web site . It is also available by email subscription . Further information: Herantis Pharma plc, Pekka Simula, CEO, telephone: +358 40 7300 445Company web site: www.herantis.com About Herantis

Magnus René appointed CEO at Ovzon. Per Wahlberg assumes new role as EVP Business Development

The Board of Directors of Ovzon today has appointed Magnus René CEO of Ovzon. The present CEO, Per Wahlberg, will assume a position as Executive Vice President, Business Development.Per Wahlberg is the founder and CEO over the 12 years since the company inception. Per Wahlberg and the Board of Directors of Ovzon have agreed to the changes and when the company now enters into a new phase this change will allow Per to concentrate his time on what he enjoys most and what is his strength, i.e. business development and innovation. Magnus René has been a director of Ovzon since May 2018 and

Preem and Vattenfall deepen partnership for the production of fossil-free fuel on a large scale

Vattenfall and Preem want to lead the transition towards a sustainable society. A new three-year agreement forms the foundation for increased collaboration around fossil-free hydrogen for biofuel production, electrification and electricity supply.The agreement provides for increased collaboration between the companies around fossil-free hydrogen for biofuel production, electrification and electricity supply. Work on the first joint project will be intensified with ongoing preparations for fossil-free hydrogen production through water electrolysis at Preem's refinery on the island of

Finland's most active workplace is also one of its most inspiring

An employee survey held in 2019 shows that Kiilto is one of Finland's most inspiring workplaces. Corporate Spirit has presented KiiltoClean Oy with an award as one of Finland’s Most Inspiring Workplaces 2019, for ranking among the best-performing companies in the PeoplePower® employee survey. In January, KiiltoClean Oy was also declared Finland's Most Active Workplace."The staff feel that their employer invests in their wellbeing and promotes their professional development. We are growing fast but, despite this change, our staff trust in senior management, view the company's recent

Nuuka Solutions signs € 0,7 million funding from Loudspring

Loudspring has extended a capital loan of up to 700 000 EUR to its portfolio company Nuuka Solutions. The loan will be disbursed in tranches and enables Nuuka to execute its growth plan, including new recruitments and entering into new markets, as well as further developing the product offering.  Lassi Noponen, CEO, Loudspring: “We are thrilled to continue supporting Nuuka on its growth journey. Real estate is the world’s largest asset class and big data in buildings is one of the most underutilized assets in the real estate market. By analyzing data and managing buildings intelligently,

Share buy-backs in Telia Company during week 18 2019

During the period April 29, 2019, until May 3, 2019, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2,823,951 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 16, 2019. The share buy-back programme, which runs between April 16, 2019, and February 28, 2020, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period April

Lundbeck to acquire Abide Therapeutics, adding a unique discovery platform and a lead compound in an exploratory phase IIa program for Tourette’s

---------------------------------------------------------------------- · Abide’s world-class discovery platform is focused on harnessing the therapeutic potential of one of the largest and most diverse enzyme classes – the serine hydrolases (SHs) – with the potential to deliver unprecedented compounds across a broad range of central nervous system (CNS) indications · Abide’s lead product ABX 1431 is a first-in-class inhibitor of monoacylglycerol lipase (MGLL), modulating the endocannabinoid system. ABX-1431 is in clinical development for Tourette’s  (exploratory phase IIa) and

CEO and Board Member subscribe for 700 KSEK

CEO Roberto Garcia Martinez and Board Member Martin Liljestrand have subscribed for 700 KSEK in addition to their subscription commitments in the on-going rights issue. This means that the board and management have altogether subscribed for approximately 1.8 MSEK in the rights issue. For more information, please contact: Roberto Garcia Martinez, VD E-post: roberto.g@orezone.se Orezone in Brief Orezone AB (publ) is a Swedish exploration company that conducts targeted mineral exploration in Europe. The Company’s business model is to acquire projects and assets, to prospect

Exercise of employee share options – follow up notice

Reference is made to the statement dated 2nd of May 2019. The payment has been determined based on a selling price of (price) per share. Siv Farstad purchased 13 810 shares at a price of 19,4854Robin Knowles purchased 36 827 shares at a price of 19,4854 After this:Siv Farstad holds 690.000 unexercised options in the Company, corresponding to 690.000 shares. After completion of the abovementioned transactions, the primary insider holds 294.810 shares in the Company. Robin Knowles holds 1.840.000 unexercised options in the Company, corresponding to 1.840.000 shares. After

Operational EBIT of DKK 268 Million for the First Quarter of 2019

(Figures in parenthesis refer to the same period last year unless otherwise specified) The Bakkafrost Group delivered a total operating EBIT of DKK 267.7 million in Q1 2019. Harvested volumes were 13.7 thousand tonnes gutted weight. The combined farming and VAP segments made an operational EBIT of DKK 231.1 million. The farming segment made an operational EBIT of DKK 229.7 million. The salmon spot price increased in the quarter, compared to Q4 2018 and to Q1 2018. Bakkafrost’s achieved prices in this quarter, however, were lower than in Q1 2018, and thus had a negative effect on the

AlzeCure changes direction for its drug candidate ACD855 within the NeuroRestore platform

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that they will redirect the drug candidate ACD855 within the research platform NeuroRestore from cognitive dysfunction to an indication in the eye instead. This means that the ongoing Phase I clinical studies with ACD855 will be terminated and that the substance instead will be tested for one of the previously planned indications instead.ACD855 has so far proved to be safe in humans, but it exhibits a longer half-life in humans than expected, which means that the company considers it more suitable for local administration than

STÄMMOKOMMUNIKÉ FRÅN ÅRSSTÄMMA I FLEXQUBE AB (PUBL)

Pressmeddelande 2019-05-03, kl. 18:45Vid årsstämman i FlexQube AB (publ) den 3 maj 2019 fattades bland annat följande beslut. Beslut om fastställande av resultaträkning och balansräkning samt koncernresultaträkning och koncernbalansräkning Årsstämman beslutade att fastställa av styrelsen framlagd resultat- och balansräkning för FlexQube AB (publ) och koncernen. Beslut om disposition beträffande bolagets vinst eller förlust enligt den fastställda balansräkningen Årsstämman beslutade att balansera vinsten i ny räkning och att inte lämna någon utdelning till aktieägarna. Beslut

ABB powers tourists to the Niagara Falls with first US built all-electric vessels

Niagara Falls, New York, US, May 3, 2019 - Niagara Falls tour operator Maid of the Mist orders two new passenger vessels sailing on pure electric power, enabled by ABB’s technology Visitors to the iconic Niagara Falls will soon be able to experience one of the US’s top landmarks emission-free. Two new Maid of the Mist passenger vessels will be powered entirely by high-capacity battery packs, becoming the first all-electric vessels ever built in the US. The new vessels will benefit from ABB’s zero-emission technology when they start operating later this year, allowing guests to

More from the Company Monthly Newsletter April 2019

During the month of April we continued our development and documentation work, participated at the Innovation week event at LTH as well as the first SME-Sweden meeting, and introduced two new employees; Jim Hansson and Håkan Erlandsson.We exhibited at the Innovation Week at Lund University where we met many students, and some 30 other companies in Lund from various industries that participated at the same event. This is an annual event at Lund University. Read more on: https://iwtlth.se/ Björn Wallin, CEO at Recall Capital, has together with PwC and DLA Piper, taken the initiative to

Acquisition of shares by primary insiders

Oslo, 3 May 2019 Today, 3 May 2019, a total of 178,382 shares in DNB ASA were acquired on behalf of certain leading employees and risk takers. The purchase was executed collectively at an average price per share of NOK 159.5625. The shares were acquired in accordance with the regulation on remuneration in financial institutions etc., which states that at least half of annual variable remuneration shall be awarded as shares and be subject to certain lock-up mechanisms. The employees have been given a compensation for decreased share value resulting from the lock-up at approximately

Tikkurila Oyj - Managers' Transactions, Lindfors Lars Peter

Tikkurila OyjManagers’ transactionsMay 3, 2019 at 5.55 p.m. Tikkurila Oyj - Managers' Transactions, Lindfors Lars Peter ____________________________________________ Person subject to the notification requirement Name: Lindfors Lars Peter Position: Member of the Board/Deputy member Issuer: Tikkurila Oyj LEI: 743700PKLY067IZIF588 Notification type: INITIAL NOTIFICATION Reference number: 743700PKLY067IZIF588_20190503160350_3 ____________________________________________ Transaction date: 2019-04-30 Venue: OFF-EXCHANGE TRANSACTIONS (XOFF) Instrument

Tikkurila Oyj - Managers' Transactions, Mynttinen Riitta

Tikkurila OyjManagers’ transactionsMay 3, 2019 at 5.55 p.m. Tikkurila Oyj - Managers' Transactions, Mynttinen Riitta ____________________________________________ Person subject to the notification requirement Name: Mynttinen Riitta Position: Member of the Board/Deputy member Issuer: Tikkurila Oyj LEI: 743700PKLY067IZIF588 Notification type: INITIAL NOTIFICATION Reference number: 743700PKLY067IZIF588_20190503160325_4 ____________________________________________ Transaction date: 2019-04-30 Venue: OFF-EXCHANGE TRANSACTIONS (XOFF) Instrument type:

Tikkurila Oyj - Managers' Transactions, Paasikivi Jari

Tikkurila OyjManagers’ transactionsMay 3, 2019 at 5.55 p.m. Tikkurila Oyj - Managers' Transactions, Paasikivi Jari ____________________________________________ Person subject to the notification requirement Name: Paasikivi Jari Position: Member of the Board/Deputy member Issuer: Tikkurila Oyj LEI: 743700PKLY067IZIF588 Notification type: INITIAL NOTIFICATION Reference number: 743700PKLY067IZIF588_20190503160258_4 ____________________________________________ Transaction date: 2019-04-30 Venue: OFF-EXCHANGE TRANSACTIONS (XOFF) Instrument type: SHARE

Tikkurila Oyj - Managers' Transactions, Sahlgren Catherine

Tikkurila OyjManagers’ transactionsMay 3, 2019 at 5.55 p.m. Tikkurila Oyj - Managers' Transactions, Sahlgren Catherine ____________________________________________ Person subject to the notification requirement Name: Sahlgren Catherine Position: Member of the Board/Deputy member Issuer: Tikkurila Oyj LEI: 743700PKLY067IZIF588 Notification type: INITIAL NOTIFICATION Reference number: 743700PKLY067IZIF588_20190503160238_3 ____________________________________________ Transaction date: 2019-04-30 Venue: OFF-EXCHANGE TRANSACTIONS (XOFF) Instrument type:

There are no items matching the current filter
There are no more items matching the current filter
Back to top